Your browser doesn't support javascript.
loading
RNase H2, mutated in Aicardi-Goutières syndrome, promotes LINE-1 retrotransposition.
Benitez-Guijarro, Maria; Lopez-Ruiz, Cesar; Tarnauskaite, Zygimante; Murina, Olga; Mian Mohammad, Mahwish; Williams, Thomas C; Fluteau, Adeline; Sanchez, Laura; Vilar-Astasio, Raquel; Garcia-Canadas, Marta; Cano, David; Kempen, Marie-Jeanne Hc; Sanchez-Pozo, Antonio; Heras, Sara R; Jackson, Andrew P; Reijns, Martin Am; Garcia-Perez, Jose L.
Afiliação
  • Benitez-Guijarro M; GENYO, Centro de Genómica e Investigación Oncológica: Pfizer - Universidad de Granada - Junta de Andalucía, PTS, Granada, Spain.
  • Lopez-Ruiz C; GENYO, Centro de Genómica e Investigación Oncológica: Pfizer - Universidad de Granada - Junta de Andalucía, PTS, Granada, Spain.
  • Tarnauskaite Z; MRC Human Genetics Unit, MRC, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
  • Murina O; MRC Human Genetics Unit, MRC, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
  • Mian Mohammad M; MRC Human Genetics Unit, MRC, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
  • Williams TC; MRC Human Genetics Unit, MRC, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
  • Fluteau A; MRC Human Genetics Unit, MRC, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
  • Sanchez L; GENYO, Centro de Genómica e Investigación Oncológica: Pfizer - Universidad de Granada - Junta de Andalucía, PTS, Granada, Spain.
  • Vilar-Astasio R; GENYO, Centro de Genómica e Investigación Oncológica: Pfizer - Universidad de Granada - Junta de Andalucía, PTS, Granada, Spain.
  • Garcia-Canadas M; GENYO, Centro de Genómica e Investigación Oncológica: Pfizer - Universidad de Granada - Junta de Andalucía, PTS, Granada, Spain.
  • Cano D; GENYO, Centro de Genómica e Investigación Oncológica: Pfizer - Universidad de Granada - Junta de Andalucía, PTS, Granada, Spain.
  • Kempen MH; MRC Human Genetics Unit, MRC, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
  • Sanchez-Pozo A; Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain.
  • Heras SR; GENYO, Centro de Genómica e Investigación Oncológica: Pfizer - Universidad de Granada - Junta de Andalucía, PTS, Granada, Spain.
  • Jackson AP; Department of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain.
  • Reijns MA; MRC Human Genetics Unit, MRC, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK.
  • Garcia-Perez JL; MRC Human Genetics Unit, MRC, Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, UK martin.reijns@igmm.ed.ac.uk jose.garcia-perez@igmm.ed.ac.uk.
EMBO J ; 37(15)2018 08 01.
Article em En | MEDLINE | ID: mdl-29959219
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonuclease H / Elementos Nucleotídeos Longos e Dispersos / Doenças Autoimunes do Sistema Nervoso / Malformações do Sistema Nervoso Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonuclease H / Elementos Nucleotídeos Longos e Dispersos / Doenças Autoimunes do Sistema Nervoso / Malformações do Sistema Nervoso Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article